mTOR inhibitors vs chemotherapy/hormone therapy
Quality of life ‐ not reported · women with advanced or recurrent endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
- PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found